Replies to post #30473 on Marker Therapeutics Inc (MRKR)

[hanscott]

Gitta, ok, so

"Baylor" is doing the research for Multi-TAA and they are the research team for MRKR. So MRKR personnel are doing the ongoing research and clinical trials.

Mayo is for the Tapimmune legacy vaccines and afaik and are not directly tied to MRKR corporate afaik. But

I think you might not have an appreciation for what goes into the process of working with the FDA, planning and setting up the new MRKR Corp building being leased, recruiting and organizing clinical trial, and continuing any and all ongoing research in the lab.

For example, they might be working at the bench on polystart, or consider what went into forming the modifications to the clinical protocol, etc (there are sooo many "etc, etc" in research). There are Always loose ends to be followed up on and new avenues being explored in preliminary research that we shareholders are not goin to be aware of.

I promise you no one is standing around surfing the web all day on their phones, or golfing with Trump and the ShadyDeals Resort.

I'm not a philanthropist (full on rapist) either. But this is the nature of the beast. It is what it is in terms of communication with shareholders.

Now I gotta git :)

"Patience is a virtue, I have none of either."
We shareholders in up to our eyeballs.